questionsmedicales.fr
Systèmes sanguin et immunitaire
Système immunitaire
Leucocytes
Agranulocytes
Lymphocytes
Lymphocytes T
Sous-populations de lymphocytes T
Lymphocytes T cytotoxiques
Lymphocytes T cytotoxiques : Questions médicales fréquentes
Termes MeSH sélectionnés :
Diagnostic
5
Déficience immunitaire
Lymphocytes T
Tests immunologiques
Cytotoxicité
Cytokines
Tests immunologiques
Lymphocytes T
Analyse sanguine
Immunophénotypage
Marqueurs cellulaires
Lymphocytes T
CD8
Réponse immunitaire
Cytokines
Prolifération cellulaire
Symptômes
5
Infections
Fatigue
Maladies auto-immunes
Santé mentale
Infections
Lymphocytes T
Fièvre
Inflammation
Éruptions cutanées
Allergies
Lymphocytes T
Réaction immunitaire
Tumeurs
Cytotoxicité
Lymphocytes T
Prévention
5
Prévention des infections
Vaccination
Hygiène
Régime alimentaire
Nutriments
Système immunitaire
Stress
Immunité
Lymphocytes T
Sommeil
Réponse immunitaire
Lymphocytes T
Compléments alimentaires
Vitamine D
Lymphocytes T
Traitements
5
Immunothérapie
Inhibiteurs de points de contrôle
Lymphocytes T
Vaccins
Réponse immunitaire
Lymphocytes T
Transfusions
Thérapie cellulaire
Cancer
Corticostéroïdes
Immunosuppresseurs
Lymphocytes T
Thérapie génique
Lymphocytes T
Cancer
Complications
5
Infections opportunistes
Cancer
Déficience immunitaire
Maladies auto-immunes
Lymphocytes T
Activation immunitaire
Greffe d'organe
Rejet
Lymphocytes T
Allergies
Réponse immunitaire
Lymphocytes T
Suractivation
Maladies inflammatoires
Lymphocytes T
Facteurs de risque
5
Âge avancé
Diabète
Immunosuppression
Tabagisme
Lymphocytes T
Immunité
Maladies chroniques
VIH
Lymphocytes T
Toxines
Lymphocytes T
Fonction immunitaire
Stress psychologique
Lymphocytes T
Infections
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Lymphocytes T cytotoxiques : Questions médicales les plus fréquentes",
"headline": "Lymphocytes T cytotoxiques : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Lymphocytes T cytotoxiques : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-04-19",
"dateModified": "2026-04-09",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Lymphocytes T cytotoxiques"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Sous-populations de lymphocytes T",
"url": "https://questionsmedicales.fr/mesh/D016176",
"about": {
"@type": "MedicalCondition",
"name": "Sous-populations de lymphocytes T",
"code": {
"@type": "MedicalCode",
"code": "D016176",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "A15.382.490.555.567.569.500"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Lymphocytes T cytotoxiques",
"alternateName": "T-Lymphocytes, Cytotoxic",
"code": {
"@type": "MedicalCode",
"code": "D013602",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Jens Rettig",
"url": "https://questionsmedicales.fr/author/Jens%20Rettig",
"affiliation": {
"@type": "Organization",
"name": "Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany."
}
},
{
"@type": "Person",
"name": "Markus Hoth",
"url": "https://questionsmedicales.fr/author/Markus%20Hoth",
"affiliation": {
"@type": "Organization",
"name": "Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany. Electronic address: markus.hoth@uks.eu."
}
},
{
"@type": "Person",
"name": "Gillian M Griffiths",
"url": "https://questionsmedicales.fr/author/Gillian%20M%20Griffiths",
"affiliation": {
"@type": "Organization",
"name": "Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK."
}
},
{
"@type": "Person",
"name": "Keerthana Ravichandran",
"url": "https://questionsmedicales.fr/author/Keerthana%20Ravichandran",
"affiliation": {
"@type": "Organization",
"name": "Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany."
}
},
{
"@type": "Person",
"name": "Elmar Krause",
"url": "https://questionsmedicales.fr/author/Elmar%20Krause",
"affiliation": {
"@type": "Organization",
"name": "Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Perivascular invasion of primary human glioblastoma cells in organotypic human brain slices: human cells migrating in human brain.",
"datePublished": "2023-07-25",
"url": "https://questionsmedicales.fr/article/37490233",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1007/s11060-023-04349-9"
}
},
{
"@type": "ScholarlyArticle",
"name": "Human",
"datePublished": "2024-05-29",
"url": "https://questionsmedicales.fr/article/38807524",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsif.2024.0074"
}
},
{
"@type": "ScholarlyArticle",
"name": "On human-in-the-loop optimization of human-robot interaction.",
"datePublished": "2024-09-25",
"url": "https://questionsmedicales.fr/article/39322732",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41586-024-07697-2"
}
},
{
"@type": "ScholarlyArticle",
"name": "Development of a thermodynamics of human cognition and human culture.",
"datePublished": "2023-08-14",
"url": "https://questionsmedicales.fr/article/37573880",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1098/rsta.2022.0378"
}
},
{
"@type": "ScholarlyArticle",
"name": "Industry 5 and the Human in Human-Centric Manufacturing.",
"datePublished": "2023-07-14",
"url": "https://questionsmedicales.fr/article/37514710",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3390/s23146416"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Systèmes sanguin et immunitaire",
"item": "https://questionsmedicales.fr/mesh/D006424"
},
{
"@type": "ListItem",
"position": 3,
"name": "Système immunitaire",
"item": "https://questionsmedicales.fr/mesh/D007107"
},
{
"@type": "ListItem",
"position": 4,
"name": "Leucocytes",
"item": "https://questionsmedicales.fr/mesh/D007962"
},
{
"@type": "ListItem",
"position": 5,
"name": "Agranulocytes",
"item": "https://questionsmedicales.fr/mesh/D007963"
},
{
"@type": "ListItem",
"position": 6,
"name": "Lymphocytes",
"item": "https://questionsmedicales.fr/mesh/D008214"
},
{
"@type": "ListItem",
"position": 7,
"name": "Lymphocytes T",
"item": "https://questionsmedicales.fr/mesh/D013601"
},
{
"@type": "ListItem",
"position": 8,
"name": "Sous-populations de lymphocytes T",
"item": "https://questionsmedicales.fr/mesh/D016176"
},
{
"@type": "ListItem",
"position": 9,
"name": "Lymphocytes T cytotoxiques",
"item": "https://questionsmedicales.fr/mesh/D013602"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Lymphocytes T cytotoxiques - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Lymphocytes T cytotoxiques",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2026-05-16",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Lymphocytes T cytotoxiques",
"description": "Comment diagnostiquer une déficience en T-Lymphocytes cytotoxiques ?\nQuels tests évaluent l'activité des T-Lymphocytes cytotoxiques ?\nPeut-on mesurer les T-Lymphocytes cytotoxiques dans le sang ?\nQuels marqueurs sont utilisés pour identifier les T-Lymphocytes cytotoxiques ?\nComment évaluer la réponse immunitaire des T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602?mesh_terms=Humans#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Lymphocytes T cytotoxiques",
"description": "Quels symptômes indiquent une défaillance des T-Lymphocytes ?\nLes T-Lymphocytes cytotoxiques affectent-ils la santé mentale ?\nQuels signes cliniques révèlent une activation des T-Lymphocytes ?\nLes T-Lymphocytes cytotoxiques causent-ils des symptômes allergiques ?\nComment les T-Lymphocytes cytotoxiques affectent-ils les tumeurs ?",
"url": "https://questionsmedicales.fr/mesh/D013602?mesh_terms=Humans#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Lymphocytes T cytotoxiques",
"description": "Comment prévenir les infections liées aux T-Lymphocytes ?\nLes régimes alimentaires influencent-ils les T-Lymphocytes ?\nLe stress affecte-t-il les T-Lymphocytes ?\nComment le sommeil impacte-t-il les T-Lymphocytes ?\nLes compléments alimentaires aident-ils les T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602?mesh_terms=Humans#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Lymphocytes T cytotoxiques",
"description": "Quels traitements renforcent les T-Lymphocytes cytotoxiques ?\nComment les vaccins influencent-ils les T-Lymphocytes ?\nLes transfusions de T-Lymphocytes sont-elles possibles ?\nQuels médicaments ciblent les T-Lymphocytes cytotoxiques ?\nComment la thérapie génique affecte-t-elle les T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602?mesh_terms=Humans#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Lymphocytes T cytotoxiques",
"description": "Quelles complications peuvent survenir avec des T-Lymphocytes défaillants ?\nLes T-Lymphocytes peuvent-ils causer des maladies auto-immunes ?\nComment les T-Lymphocytes affectent-ils la greffe d'organe ?\nLes T-Lymphocytes sont-ils impliqués dans les allergies ?\nQuelles sont les conséquences d'une suractivation des T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602?mesh_terms=Humans#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Lymphocytes T cytotoxiques",
"description": "Quels facteurs augmentent le risque d'infections liées aux T-Lymphocytes ?\nLe tabagisme affecte-t-il les T-Lymphocytes ?\nLes maladies chroniques influencent-elles les T-Lymphocytes ?\nL'exposition à des toxines affecte-t-elle les T-Lymphocytes ?\nLe stress psychologique influence-t-il les T-Lymphocytes ?",
"url": "https://questionsmedicales.fr/mesh/D013602?mesh_terms=Humans#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostiquer une déficience en T-Lymphocytes cytotoxiques ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des tests sanguins mesurant les niveaux de lymphocytes T et des tests fonctionnels sont utilisés."
}
},
{
"@type": "Question",
"name": "Quels tests évaluent l'activité des T-Lymphocytes cytotoxiques ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests de cytotoxicité, comme le test de libération de cytokines, évaluent leur activité."
}
},
{
"@type": "Question",
"name": "Peut-on mesurer les T-Lymphocytes cytotoxiques dans le sang ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, par des analyses de sang qui quantifient les sous-populations de lymphocytes T."
}
},
{
"@type": "Question",
"name": "Quels marqueurs sont utilisés pour identifier les T-Lymphocytes cytotoxiques ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les marqueurs CD8+ sont typiquement utilisés pour identifier ces lymphocytes."
}
},
{
"@type": "Question",
"name": "Comment évaluer la réponse immunitaire des T-Lymphocytes ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "On utilise des tests de prolifération cellulaire et de production de cytokines."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une défaillance des T-Lymphocytes ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections fréquentes, fatigue persistante et maladies auto-immunes peuvent survenir."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes cytotoxiques affectent-ils la santé mentale ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, par le biais d'infections chroniques qui peuvent influencer l'humeur."
}
},
{
"@type": "Question",
"name": "Quels signes cliniques révèlent une activation des T-Lymphocytes ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, inflammation et éruptions cutanées peuvent indiquer une activation immunitaire."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes cytotoxiques causent-ils des symptômes allergiques ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, ils ne sont pas directement responsables des allergies, mais d'autres lymphocytes le sont."
}
},
{
"@type": "Question",
"name": "Comment les T-Lymphocytes cytotoxiques affectent-ils les tumeurs ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils reconnaissent et détruisent les cellules tumorales, limitant la croissance des tumeurs."
}
},
{
"@type": "Question",
"name": "Comment prévenir les infections liées aux T-Lymphocytes ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Vaccination, hygiène et un mode de vie sain renforcent le système immunitaire."
}
},
{
"@type": "Question",
"name": "Les régimes alimentaires influencent-ils les T-Lymphocytes ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une alimentation riche en nutriments peut soutenir la fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Le stress affecte-t-il les T-Lymphocytes ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress chronique peut diminuer leur efficacité et affaiblir l'immunité."
}
},
{
"@type": "Question",
"name": "Comment le sommeil impacte-t-il les T-Lymphocytes ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un sommeil adéquat est crucial pour maintenir une réponse immunitaire optimale."
}
},
{
"@type": "Question",
"name": "Les compléments alimentaires aident-ils les T-Lymphocytes ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains compléments, comme la vitamine D, peuvent soutenir leur fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Quels traitements renforcent les T-Lymphocytes cytotoxiques ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les immunothérapies, comme les inhibiteurs de points de contrôle, stimulent leur activité."
}
},
{
"@type": "Question",
"name": "Comment les vaccins influencent-ils les T-Lymphocytes ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les vaccins peuvent activer les T-Lymphocytes cytotoxiques pour combattre les infections."
}
},
{
"@type": "Question",
"name": "Les transfusions de T-Lymphocytes sont-elles possibles ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des thérapies cellulaires adoptives transfusent des T-Lymphocytes pour traiter le cancer."
}
},
{
"@type": "Question",
"name": "Quels médicaments ciblent les T-Lymphocytes cytotoxiques ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les corticostéroïdes et les agents immunosuppresseurs peuvent inhiber leur fonction."
}
},
{
"@type": "Question",
"name": "Comment la thérapie génique affecte-t-elle les T-Lymphocytes ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Elle peut modifier les T-Lymphocytes pour améliorer leur capacité à cibler les cellules cancéreuses."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des T-Lymphocytes défaillants ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Infections opportunistes et cancers peuvent se développer en raison d'une immunité affaiblie."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes peuvent-ils causer des maladies auto-immunes ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, une activation inappropriée peut entraîner des maladies auto-immunes."
}
},
{
"@type": "Question",
"name": "Comment les T-Lymphocytes affectent-ils la greffe d'organe ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Ils peuvent provoquer le rejet de greffe en attaquant les cellules étrangères."
}
},
{
"@type": "Question",
"name": "Les T-Lymphocytes sont-ils impliqués dans les allergies ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Indirectement, car une réponse immunitaire inappropriée peut contribuer aux allergies."
}
},
{
"@type": "Question",
"name": "Quelles sont les conséquences d'une suractivation des T-Lymphocytes ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une suractivation peut entraîner des maladies inflammatoires et des dommages tissulaires."
}
},
{
"@type": "Question",
"name": "Quels facteurs augmentent le risque d'infections liées aux T-Lymphocytes ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'âge avancé, le diabète et l'immunosuppression augmentent le risque d'infections."
}
},
{
"@type": "Question",
"name": "Le tabagisme affecte-t-il les T-Lymphocytes ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le tabagisme peut altérer la fonction des T-Lymphocytes et affaiblir l'immunité."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques influencent-elles les T-Lymphocytes ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des maladies comme le VIH ou le cancer peuvent réduire leur nombre et leur fonction."
}
},
{
"@type": "Question",
"name": "L'exposition à des toxines affecte-t-elle les T-Lymphocytes ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines toxines environnementales peuvent compromettre leur fonction immunitaire."
}
},
{
"@type": "Question",
"name": "Le stress psychologique influence-t-il les T-Lymphocytes ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, le stress psychologique peut diminuer leur efficacité et augmenter le risque d'infections."
}
}
]
}
]
}
Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale
Validation scientifique effectuée le 09/04/2026
Contenu vérifié selon les dernières recommandations médicales
4 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany. Electronic address: markus.hoth@uks.eu.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
3 publications dans cette catégorie
Affiliations :
Department of Life Sciences, University of Siena, 53100, Siena, Italy.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Biophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Biophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Biophysics, Center for Integrative Physiology and Molecular Medicine (CIPMM), School of Medicine, Saarland University, Homburg, Germany.
INM - Leibniz Institute for New Materials, Saarbrücken, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Cellular Neurophysiology, Center for Integrative Physiology and Molecular Medicine (CIPMM), Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Department of Biophysics, Center for Integrative Physiology and Molecular Medicine, Medical Faculty, Saarland University, Homburg, Germany.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Cambridge Institute for Medical Research, Keith Peters Building, Cambridge CB2 0XY, UK.
Experimental Cancer Genetics, The Wellcome Trust Sanger Institute, Hinxton, Cambridge, UK.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
State Key Laboratory of Common Mechanism Research for Major Diseases, Department of Pharmacology, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, School of Basic Medicine, Peking Union Medical College, Beijing, China.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Center for Hematology and Regenerative Medicine (HERM), Karolinska Institute, Stockholm, Sweden.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Neurovirology Laboratory, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Neurovirology Laboratory, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
Neurovirology Laboratory, Department of Medicine, University of Minnesota Medical School, Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
2 publications dans cette catégorie
Affiliations :
3-107 Microbiology Research Facility, University of Minnesota, 689 23rd Avenue S.E., Minneapolis, MN 55455, USA.
Publications dans "Lymphocytes T cytotoxiques" :
Glioblastoma (GBM) is an aggressive primary brain cancer. Lack of effective therapy is related to its highly invasive nature. GBM invasion has been studied with reductionist systems that do not fully ...
Non-tumor brain samples were obtained from patients undergoing surgery (n = 7). Organotypic brain slices were prepared, and green fluorescent protein (GFP)-labeled primary human GBM IDH-wild type cell...
After placement, cells migrated towards blood vessels; initially migrating with limited directionality, sending processes in different directions, and increasing their speed upon contact with the vess...
Human organotypic models can accurately study cell migration ex vivo. GBM IDH-wild type cells migrate toward the perivascular space in blood vessels and their migratory parameters change once they con...
The interaction among joints of the midtarsal complex and subtalar joint is important for locomotor function; however, its complexity poses substantial challenges in quantifying the joints' motions. W...
From industrial exoskeletons to implantable medical devices, robots that interact closely with people are poised to improve every aspect of our lives. Yet designing these systems is very challenging; ...
Inspired by foundational studies in classical and quantum physics, and by information retrieval studies in quantum information theory, we prove that the notions of 'energy' and 'entropy' can be consis...
Industry 4 (I4) was a revolutionary new stage for technological progress in manufacturing which promised a new level of interconnectedness between a diverse range of technologies. Sensors, as a point ...
As the global population rapidly ages with longer life expectancy and declining birth rates, the need for healthcare services and caregivers for older adults is increasing. Current research envisions ...
Bowers et al. express skepticism about deep neural networks (DNNs) as models of human vision due to DNNs' failures to account for results from psychological research. We argue that to fairly assess DN...
Humans can easily perform various types of hugs in human contact and affection experience. With the prevalence of robots in social applications, they would be expected to possess the capability of hug...
All human groups are equally human, but are they automatically represented as such? Harnessing data from 61,377 participants across 13 experiments (six primary and seven supplemental), a sharp dissoci...
Allogeneic stem cell transplantation (alloSCT) can be curative for hemato-oncology patients due to effective graft-versus-tumor immunity. However, relapse remains the major cause of treatment failure,...